MedPath

A clinical study on dvandva dosha chikitsa (kapha and vata) in the management of tamaka shvasa

Phase 3
Conditions
Health Condition 1: J454- Moderate persistent asthma
Registration Number
CTRI/2023/11/059741
Lead Sponsor
Dr Raviraj
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Fulfilling the Diagnostic Criteria

Avegakaleena Tamaka Shvasa subjects

Willingness to sign consent form

Exclusion Criteria

Pregnant and Lactating Woman

Subjects of active cases of COVID-19

History of tuberculosis, COPD, Ischemic Heart disease, any malignancy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reduction in breathlessnessTimepoint: 14 days intervention and follow up for 20 days
Secondary Outcome Measures
NameTimeMethod
o relapse of shvasa episode <br/ ><br>Timepoint: 14 days of intervention & 20 days of follow up
© Copyright 2025. All Rights Reserved by MedPath